Astrana Health (ASTH) FY2022 results: revenue $1.1 billion, up 47.8% on the year
Astrana Health, Inc. (ASTH) reported revenue of $1.1 billion for fiscal 2022, the year ended 31 December 2022, up 47.8% on the year before. Net income was $45 million, down 34.5%, and diluted earnings per share $0.99. The figures are the company's own, from the 10-K it filed with the SEC on 1 March 2023.
Revenue
$1.1 billion
+47.8% on the year
FY2016FY2022
Operating margin
9.1%
12.7% a year earlier
FY2016FY2022
Net income
$45 million
-34.5% on the year
FY2016FY2022
Diluted EPS
$0.99
-34.9% on the year
FY2016FY2022
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2022
FY2021
FY2020
On the year
Last 8 years
Operating cash flow
82.1
70.3
46.2
+16.8%
Capital expenditure
22.9
19.2
1.2
+19.3%
Free cash flow
59.2
51.1
45.0
+15.8%
Free cash flow margin
5.2%
6.6%
6.5%
Cash from investing
-7.1
16.5
95.5
Cash from financing
-20.1
-47.7
-51.7
Depreciation and amortisation
17.5
17.5
18.4
+0.1%
Share-based compensation
16.1
6.7
3.4
+138.7%
Buybacks
9.2
5.7
0.5
+61.2%
Dividends paid
14.0
31.1
51.3
-54.9%
Diluted shares, weighted
46m
45m
37m
+0.4%
Shares outstanding at period end
47m
45m
42m
+4.4%
Balance sheet
$ million
FY2022
FY2021
FY2020
On the year
Last 8 years
Shareholders' equity
543
448
331
+21.1%
Non-controlling interest
1.7
5.9
0.1
-70.6%
Redeemable equity
14.2
56.5
114
-74.8%
Debt
204
184
241
+11.1%
Operating lease liabilities
19.9
13.2
15.9
+50.9%
Finance lease liabilities
1.3
1.0
0.3
+31.0%
Other liabilities
182
159
116
+14.9%
Total liabilities and equity
966
867
817
+11.4%
Goodwill
269
246
232
+9.2%
Intangible assets
76.9
82.8
87.0
-7.2%
Investments
5.6
53.4
67.7
-89.6%
Cash and equivalents
288
233
193
+23.6%
Receivables
49.6
10.6
7.1
+367.9%
Other assets
277
241
230
+15.0%
Total assets
966
867
817
+11.4%
10-K for the year ended 31 December 2022, filed 1 March 2023: the filing.